Vascular Biogenics Ltd

NASDAQ:VBLT   3:59:44 PM EDT
2.05
+0.02 (+0.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)123.58M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.2 Million
Adjusted EPS-$0.13
See more estimates
10-Day MA$2.03
50-Day MA$1.95
200-Day MA$1.68
See more pivots

Vascular Biogenics Ltd Stock, NASDAQ:VBLT

8 HaSatat Street, Modiâ??in, Jerusalem 7178106
Israel
Phone: +972.8.9935000
Number of Employees: 38

Description

Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.